Details for Patent: 9,550,036
✉ Email this page to a colleague
Which drugs does patent 9,550,036 protect, and when does it expire?
Patent 9,550,036 protects TRUDHESA and is included in one NDA.
This patent has eighteen patent family members in eight countries.
Summary for Patent: 9,550,036
| Title: | Nasal drug delivery device |
| Abstract: | A compound delivery device for delivering a plume derived from a propellant and a drug formulation. The drug formulation is in an intranasal dosage form in the form of powder, suspension, dispersion or liquid. The propelled intranasal dosage form is deposited within the olfactory region of the nasal cavity. The drug deposited within the olfactory region is delivered to the brain avoiding the blood-brain-barrier. Hydrofluoroalkane propellant from a pressurized canister is channeled to a diffuser and drug-containing chamber where the intra-nasal dosage form is aerosolized. The aerosolized intra-nasal dosage form passes through a nozzle thus delivering a plume to the olfactory region of a user's nasal cavity. |
| Inventor(s): | John D. Hoekman, Michael Hite, Alan Brunelle, Joel Relethford, Rodney J. Y. Ho |
| Assignee: | Woodward Specialty LLC |
| Application Number: | US14/017,048 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; Device; Dosage form; |
Drugs Protected by US Patent 9,550,036
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impel Pharms | TRUDHESA | dihydroergotamine mesylate | SPRAY, METERED;NASAL | 213436-001 | Sep 2, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,550,036
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012223160 | ⤷ Start Trial | |||
| Australia | 2016256665 | ⤷ Start Trial | |||
| Australia | 2018256518 | ⤷ Start Trial | |||
| Brazil | 112013022249 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
